Status:
COMPLETED
Glasses Against Transmission of SARS-CoV-2 (COVID-19) in the Community
Lead Sponsor:
Norwegian Institute of Public Health
Collaborating Sponsors:
University of Basel
Conditions:
COVID-19
Respiratory Tract Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this trial the researchers plan to recruit 25,000 volunteers to be randomly allocated either wearing sunglasses or ordinary glasses in public spaces where they are close to other people, or not wea...
Detailed Description
A systematic review of observational studies indicated that eye protection may be an effective measure to prevent SARS-CoV-2 infections. Randomized trials are needed to assess whether the observed ass...
Eligibility Criteria
Inclusion
- at least 18 years of age
- owns or can borrow glasses that can be used (e.g. sun-glasses)
- willing to be randomized to wear, or not wear glasses outside the home when close to others, for a 2-week period.
- provides informed consent
Exclusion
- does regularly wear glasses (contact lenses are accepted)
- contracted COVID-19 after December 15th 2021.
Key Trial Info
Start Date :
February 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
3717 Patients enrolled
Trial Details
Trial ID
NCT05217797
Start Date
February 2 2021
End Date
December 1 2022
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norwegian Institute of Public Health
Oslo, Norway, 0213